HomeCompareCNSJF vs EQR

CNSJF vs EQR: Dividend Comparison 2026

CNSJF yields 1234.57% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CNSJF wins by $2.78M in total portfolio value
10 years
CNSJF
CNSJF
● Live price
1234.57%
Share price
$0.16
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2.82M
Annual income
$17,202.68
Full CNSJF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — CNSJF vs EQR

📍 CNSJF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCNSJFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CNSJF + EQR cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CNSJF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CNSJF
Annual income on $10K today (after 15% tax)
$104,938.27/yr
After 10yr DRIP, annual income (after tax)
$14,622.28/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, CNSJF beats the other by $9,968.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CNSJF + EQR for your $10,000?

CNSJF: 50%EQR: 50%
100% EQR50/50100% CNSJF
Portfolio after 10yr
$1.44M
Annual income
$11,339.14/yr
Blended yield
0.79%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CNSJF
No analyst data
Altman Z
1.4
Piotroski
9/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CNSJF buys
0
EQR buys
0
No recent congressional trades found for CNSJF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCNSJFEQR
Forward yield1234.57%5.87%
Annual dividend / share$2.00$3.47
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%15.8%
Portfolio after 10y$2.82M$47.8K
Annual income after 10y$17,202.68$5,475.61
Total dividends collected$1.90M$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CNSJF vs EQR ($10,000, DRIP)

YearCNSJF PortfolioCNSJF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$72,428$61,728.40$11,380$679.82+$61.0KCNSJF
2$286,418$208,920.03$13,014$837.25+$273.4KCNSJF
3$692,531$386,063.17$14,961$1,036.20+$677.6KCNSJF
4$1,177,205$436,197.13$17,297$1,289.22+$1.16MCNSJF
5$1,606,093$346,483.09$20,121$1,613.15+$1.59MCNSJF
6$1,939,415$220,895.41$23,561$2,030.84+$1.92MCNSJF
7$2,199,818$124,644.46$27,783$2,573.54+$2.17MCNSJF
8$2,419,871$66,065.59$33,013$3,284.39+$2.39MCNSJF
9$2,623,222$33,959.95$39,547$4,223.51+$2.58MCNSJF
10$2,824,050$17,202.68$47,791$5,475.61+$2.78MCNSJF

CNSJF vs EQR: Complete Analysis 2026

CNSJFStock

China Sanjiang Fine Chemicals Company Limited, an investment holding company, manufactures and supplies ethylene oxide and glycol, propylene, polypropylene, methyl tert-butyl ether (MTBE), and surfactants in the People's Republic of China. Its ethylene oxide is used as an intermediary component for the production of ethylene derivative products that include ethanolamines and glycol ethers, and a range of surfactants; ethylene glycol is used to produce other bio-organic chemical products that comprise mono ethylene glycol; propylene is used in the production of polypropylene, acrylonitrile, propylene oxide, acetone, etc.; polypropylene is a thermoplastic resin used in knitting, injection molding, film, fiber, and pipe products; MTBE, a gasoline additive used as an oxygenate to raise the octane number and used as a fuel component in fuel for gasoline engines; and surfactants are applied in various industries as scouring agents, moisturizing agents, emulsifiers, and solubilisers. The company also produces and supplies other chemical products, such as carbon four; crude pentene; and industrial gases, such as oxygen, nitrogen, and argon. In addition, it offers processing services for polypropylene, MTBE, and surfactants; and lease and storage services, as well as provides asset management and supply chain management services. Further, the company is involved in the construction and management of a pipe network at Jiaxing Port Chemical Industrial Park; manufacture and sale of fertilisers, plastics, alcohol ethoxylate, nonylphenols, textile auxiliaries, and polyethylene; and equipment rental. China Sanjiang Fine Chemicals Company Limited was incorporated in 2009 and is headquartered in Jiaxing, the People's Republic of China.

Full CNSJF Calculator →

EQRREIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this CNSJF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CNSJF vs SCHDCNSJF vs JEPICNSJF vs OCNSJF vs KOCNSJF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.